Pulse is an equity management platform focused on dental and medical practices. People need to understand how their behaviors and influence impact their organization's value and how this translates to their individual equity positions. This connection is often not well articulated or understood. Tools like Pulse can help.
Additionally, tracking and understanding equity positions becomes critical as more DSOs shift towards equity roles or smaller groups seek rapid growth beyond what bank financing allows. Offering equity, instead of higher acquisition payments, is a strategy larger groups use that smaller ones might adopt. Tools that provide clarity and illuminate the impact of equity when offering positions to others are valuable in making informed decisions and fostering growth.
Most dental sellers focus on their transaction's multiple.
However, in today's transaction structures, the multiple is just one important element. Equally important is the EBITDA figure the multiple is applied to, and the other deal terms, many which have economic consequences.
Up until about the middle of 2023, many transactions were structured so that the seller received 80% cash and was required to roll 20% equity. Due to various macroeconomic factors, there's been a big shift. Sellers might only get 50 or 60% cash and have to roll a significantly larger portion of equity.
This changes the risk-reward structure of the deal. Consequently, the conditions and terms around the equity roll, as well as the historical performance of the operator, the DSO, and the backing private equity firm, become even more important.
Understanding where your equity is held is vital.
Buyers, dental groups, and private equity firms structure this differently, but the two basic options are holding equity at your individual office level or at the top Holdco level.
Holding equity at the individual office level means you benefit only from the performance of your individual office. Conversely, holding equity at the HoldCo level allows you to benefit from the performance of all offices under that umbrella, effectively diversifying and diluting your risk across more entities rather than placing all the pressure on your individual office's performance.
Moreover, if you hold equity at your office level, you are typically entitled to annual profit share distributions proportional to your ownership position. For example, if you have a 10% equity ownership in your office, you would receive 10% of the profit each year.
On the other hand, when your equity is at the HoldCo level, the strategy often involves reinvesting all profits back into the business to foster growth. Consequently, you might not receive annual distributions, but your equity value should increase as the business grows.
Equity in DSOs presents a powerful avenue for growth and expansion.
But its complexities require a thorough understanding and strategic approach.
Sellers and prospective owners must recognize not just the immediate benefits of expanded capital access and shared resources that larger groups offer, but also the longer-term risk and reward inherent in these transactions.
Navigating this landscape with the right tools and information can help people make decisions that better align with their long-term goals.
About the Author: Maria G. Melone is a recognized thought leader, published author, and speaker with a long history of mentoring, supervising, and developing teams. She has helped facilitate hundreds of transactions and has valued even more. She has extensive dental industry knowledge and a proven ability to analyze markets, operations, and growth opportunities. Currently serving as a managing director at Caber Hill Advisors, Maria represents clients in the dental industry who are transacting with institutional investors or strategic partners.